【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 The EC (European Commission) Classification
2.2.3 IVD Classification in Australia
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-Monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.2 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.3 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.3.1 Challenges in Regulations of MDx Tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment within the In Vitro Diagnostics Market, 2015-2025
3.1 Molecular Diagnostics in the IVD Market, 2014
3.2 Sales Forecast for the Global IVD Market 2015-2025
3.3 Molecular Diagnostics Gaining A Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2015-2025
4.1 The Molecular Diagnostic Market by Sectors, 2014
4.2 The Molecular Diagnostic Market by Sectors 2015-2025
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2015-2025
4.3 The Infectious Disease Testing Market 2015-2025
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2014
4.3.1.1 CT/NG
4.3.1.2 HPV Testing
4.3.1.3 HIV
4.3.1.4 Healthcare Associated Infections (HAI)
4.3.1.5 Hepatitis C (HCV)
4.3.1.6 Respiratory Infections
4.4 The Oncology Testing Market, 2015-2025
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Prostate Cancer Pipeline Biomarkers
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2015-2025
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2015-2025
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potential beyond Oncology
4.6.3 Cystic Fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory Diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA Typing) Market 2015-2025
4.7.1 Tissue Typing: Next-Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2015-2025
5.1 Regional Breakdown of the Global MDx Market, 2014
5.2 The Global MDx Market Forecast, 2015-2025
5.3 The Regional Market Shares of the MDx Market, 2014, 2019 and 2025
5.4 The US MDx Market 2014
5.4.1 The US MDx Market Forecast 2015-2025
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast 2015-2025
5.5.1 Changes in the Shares of the Leading European Markets, 2014, 2019 and 2025
5.5.2 Shares of the Major European Markets in a Global Context
5.5.3 The German MDx Market Forecast 2015-2025
5.5.3The French MDx Market Forecast 2015-2025
5.5.4 The Italian MDx Market Forecast 2015-2025
5.5.5 The Spanish MDx Market Forecast 2015-2025
5.5.6 The UK MDx Market Forecast 2015-2025
5.5.7 The Other European MDx Markets Forecast 2015-2025
5.6 The Japanese MDx Market Forecast 2015-2025
5.7 The Chinese MDx Market Forecast 2015-2025
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2015-2025
5.9 The Russian MDx Market Forecast 2015-2025
5.10 The Indian MDx Market Forecast 2015-2025
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2015-2025
5.12 The Mexican MDx Market Forecast 2015-2025
5.13 The Rest of the World Market Forecast 2015-2025
6. The Leading Companies in the Molecular Diagnostics Market, 2015
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2015-2025
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2014
6.1.3.1 Molecular Diagnostics Sales Performance, 2014
6.1.3.2 Molecular Diagnostic Sales by Region, 2014
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2015
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2015
6.1.5 Roche: Major M&A Activity and Strategic Partnerships Strengthen Position as Market Leader
6.1.5.1 Genia Acquisition to Strengthen DNA Sequencing Capabilities
6.1.5.2 IQuum Acquisition Allows Movement into POC MDx Market
6.1.5.3 Seragon Acquisition Strengthens Leading Position in Oncology
6.1.5.4 Santaris Acquisition Enchances Roche’s Position in RNA-Targeted Drugs Market
6.1.5.5 Bina Acquisition Brings Big Data Solution to Support NGS Development
6.1.5.6 Dutalys Acquisition Enhances Roche’s mAB Portfolio
6.1.5.7 Ariosa Acquisition Adds NIPT to MDx Portfolio
6.1.5.8 Foundation Medicine Deal Enhances Personalised Medicine Capabilities for Oncology
6.1.5.9 Signature and CAPP Acquisitions Strengthen Circulating DNA Testing Abilities
6.1.5.10 GENEWEAVE and Kapa Acquisitions Help Cement Roche’s Position as the MDx Market Leader
6.2 Qiagen NV
6.2.1 Sales and Recent Performance Analysis, 2014
6.2.2 Qiagen Sales by Region, 2014
6.2.3 Qiagen Sales by Segment, 2014
6.2.4 Qiagen: Molecular Diagnostics
6.2.5 Molecular Diagnostics: Product Expansion
6.2.5.1 QIASymphony
6.2.5.2 QuantiFERON-TB Gold: Expansion into Asia
6.2.5.3 Personalised Healthcare: Collaborative Efforts
6.2.5.4 Qiagen’s Software Company Acquisitions Cement Leadership in Bioinformatics
6.3 Hologic
6.3.1 Hologic Recent Sales Performance by Business Segment, 2014
6.3.2 Hologic Molecular Diagnostics: Product Portfolio
6.4 Becton, Dickinson and Company
6.4.1 Sales and Financial Performance, 2014
6.4.2 Sales and Financial Performance by Region, 2014
6.4.3 Becton, Dickinson and Company Diagnostics Sales and Financial Performance, 2013-2014
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 bioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2014
6.5.2 Sales by Region, 2014
6.5.3 Sales by Technology, 2014
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaborations with GSK and Novartis
6.5.6 Mergers, Acquisitions and Collaborations
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2014
6.6.2 Sales by Industry Segment, 2013-2014
6.6.3 Sales by Region, 2012-2014
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent Technologies
6.7.1 Sales and Recent Performance Analysis, 2014
6.7.2 Sales Performance by Business Segment, 2014
6.7.3 Agilent Technologies: Strong Player in Target Enrichment for Next-Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2015-2025
7.1 MDx Market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2015-2025
7.2.1 Strengths
7.2.1.1 Patient Demographics
7.2.1.2 Increased Awareness
7.2.1.3 High Growth in Oncology Molecular Diagnostics
7.2.1.4 Increasing Laboratory Test Menus
7.2.1.5 Personalised Medicine: Optimising Treatment Outcomes
7.2.2 Weaknesses
7.2.2.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.2.2.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.2.2.3 Consolidation of Healthcare Systems Increases Pricing Pressure
7.2.2.4 MDx: An Expensive, but Undervalued Diagnostic Tool
7.2.3 Opportunities
7.2.3.1 Next-Generation Sequencing
7.2.3.2 Emerging Markets
7.2.3.3 The Emergence of New Microorganisms
7.2.4 Threats
7.2.4.1 US Medical Device Excise Tax
7.2.4.2 Gene Patents: Controversial Ruling
7.3 Porter’s Five Forces Analysis of the MDx Market
7.3.1 Rivalry among Competitors [High]
7.3.2 Threat of New Entrants [Medium]
7.3.3 Power of Suppliers [Medium]
7.3.4 Power of Buyers [High]
7.3.5 Threat of Substitutes [High]
8. Research Interview
8.1 Kai te Kaat, Vice President, Global Product Management Life Sciences, Head of NGS Program, QIAGEN NV
8.1.1 QIAGEN: Pioneers in NGS Technology
8.1.2 The Future of NGS Outside Oncology
8.1.3 QIAGEN: Leading Progress in Bioinformatics
8.1.4 Regional Demand for NGS and NGS in the Wider Diagnostics Market
9. Conclusion
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
10. Glossary
【レポート販売概要】
■ タイトル：分子診断（MDx）の世界市場：感染症検査、腫瘍検査、血液検査、遺伝子検査、組織適合検査（HLA）■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies
■ 発行日：2015年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN5102608
■ 調査対象地域：グローバル
- 自動車用接着剤の世界市場：ポリウレタン系接着剤、エポキシ系接着剤、アクリル系接着剤、シリコーン系接着剤、SMP接着剤、ポリアミド接着剤The global automotive adhesive market (2015–2020) is estimated to reach USD 5.56 Billion by 2020 at a CAGR of 8.2%. The automotive adhesives market is driven by rising use of adhesives in vehicles for weight reduction as well as to increase the fuel efficiency. The automotive industry is using lightweight materials such as plastics, composites, and aluminum, which ultimately require adhesives. So, …
- 中国の電力ケーブル市場2016-2020About Power Cable A power cable is primarily an assembly of one or more electrical conductors, usually held together by an overall sheath. Power cables are used for transmission and, in some cases, distribution of large quantities of electrical power. Power cables have three basic components, namely, conductor, insulation, and protective covering or sheath. Other than the three basic components, t …
- 医療レポート：Systemic Lupus Erythematosus-疫学予測（～2022）EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022 Summary Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. The disease has unp …
- ラピッドプロトタイピング装置の世界市場2017-2021About Rapid Prototyping EquipmentA group of techniques used to fabricate a model of a part or the entire assembly is known as rapid prototyping. 3D computer-aided design data are used for prototyping. Various rapid prototyping technologies such as stereolithography (SLA), selective laser sintering (SLS), laminated object manufacturing (LOM), fuel deposition modeling (FDM), solid ground curing (SGC …
- アメリカの仮想・遠隔実験室市場2016-2020About the Virtual and Remote Laboratories Market Virtual laboratories are set up on an online platform and are used to create simulation of a science process or explanation of a subject. Advanced computer languages, such as MatLab and LabView, are used to develop these laboratories. They offer anywhere, anytime access to experiments and are designed for a specific subject or a course. Through this …
- 世界のNAS市場動向（2012-2016）TechNavio's analysts forecast Global NAS market to grow at a CAGR of 21.58 percent over the period 2012-2016. One of the key factors contributing to this market growth is need for cheaper and efficient storage infrastructure. The Global NAS market has also been witnessing mixed adoption of storage components. However, increasing congestion of enterprise networks could pose a challenge to the growt …
- 世界のAPETフィルム市場2015Global APET Film Industry Report 2015 is a professional and in-depth study on the current state of the APET Film industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The APET Film market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions …
- 妊娠検査キットの世界市場2015-2019About Pregnancy Detection Kits Pregnancy detection kits are diagnostic products that check for chemical markers related to pregnancy. These kits take up the midstream format, which is one of the three categories under rapid pregnancy tests. The remaining two are the strip format and the card or cassette format. A pregnancy detection kit uses rapid chromatographic immunoassay technique for the dete …
- モーション・シミュレーションの世界市場2016-2020About Motion Simulation A motion simulation-driven approach to product design and development reduces the probability of issues by enabling the engineering teams to assess the performance of their designs quickly under a range of operating parameters at the component, system, and process levels. With the help of simulation software, product designers can quickly analyze how multiple physics influe …
- QEP Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012QEP Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary QEP Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- ストリーミング分析ソリューションの世界市場Streaming analytics have become an important tool for businesses to remain competitive among the competitors in the global market. The streaming analytics market has been segmented by various industry verticals and the major applications of streaming analytics platforms within these verticals. Streaming analytics providers play a vital role in assisting various organizations in quickly reacting to …
- IAM（アイデンティティ・アクセス管理）の世界市場：プロビジョニング、ディレクトリサービス、パスワード管理、SSO、監査、コンプライアンス、ガバナンスThe identity and access management market is expected to grow from USD 7.20 Billion in 2015 to USD 12.78 Billion by 2020, at a CAGR of 12.2% during the forecast period. Growing emphasis on compliance management, increasing trend of mobility, and growing demand from BFSI, telecommunication, public, and critical infrastructure sectors across the globe are the top driving factor of IAM market. Audit, …
- 世界におけるタクシー配車サービス企業のIT支出市場About IT spending by cab aggregators Cab aggregator model is the fastest growing cab service model in the organized taxi market. Aggregator model requires low capital expenditure and innovative cab service delivery system, which provides enhanced cab service experience to cab riders. App-based tax provider companies are globally recognized for their unique offerings to cab riders, which are forcin …
- Petroleo Brasileiro S.A.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Petroleo Brasileiro S.A. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Petroleo Brasileiro S.A. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 石油・ガス産業向けプロセス安全システムの世界市場About Process Safety Systems Safety systems are designed to protect personnel and the environment during plant operations if/when a process goes beyond the defined control margins. There are various types of safety systems including fire and gas safety systems and burner gas management. These safety systems are used across various process industries such as Oil and Gas, Chemical, Refining, Power, …
